Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

549 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development of standard clinical endpoints for use in dengue interventional trials: introduction and methodology.
Jaenisch T, Hendrickx K, Erpicum M, Agulto L, Tomashek KM, Dempsey W, Siqueira JB, Marks MA, Fay MP, Laughlin C, L'Azou M, Leo YS, Narvaez F, Teyssou R, Thomas SJ, Tissera H, Wallace D, Wilder-Smith A, Gubler DJ, Cassetti MC. Jaenisch T, et al. Among authors: thomas sj. BMC Med Res Methodol. 2018 Nov 15;18(1):134. doi: 10.1186/s12874-018-0601-z. BMC Med Res Methodol. 2018. PMID: 30442099 Free PMC article.
Critical issues in dengue vaccine development.
Thomas SJ, Endy TP. Thomas SJ, et al. Curr Opin Infect Dis. 2011 Oct;24(5):442-50. doi: 10.1097/QCO.0b013e32834a1b0b. Curr Opin Infect Dis. 2011. PMID: 21799408 Review.
Dengue human infection model: introduction.
Cassetti MC, Thomas SJ. Cassetti MC, et al. Among authors: thomas sj. J Infect Dis. 2014 Jun 15;209 Suppl 2(Suppl 2):S37-9. doi: 10.1093/infdis/jiu061. J Infect Dis. 2014. PMID: 24872393 Free PMC article. No abstract available.
Fast-Track Zika Vaccine Development - Is It Possible?
Thomas SJ, L'Azou M, Barrett AD, Jackson NA. Thomas SJ, et al. N Engl J Med. 2016 Sep 29;375(13):1212-6. doi: 10.1056/NEJMp1609300. N Engl J Med. 2016. PMID: 27682032 Free article. No abstract available.
Clinical development and regulatory points for consideration for second-generation live attenuated dengue vaccines.
Vannice KS, Wilder-Smith A, Barrett ADT, Carrijo K, Cavaleri M, de Silva A, Durbin AP, Endy T, Harris E, Innis BL, Katzelnick LC, Smith PG, Sun W, Thomas SJ, Hombach J. Vannice KS, et al. Among authors: thomas sj. Vaccine. 2018 Jun 7;36(24):3411-3417. doi: 10.1016/j.vaccine.2018.02.062. Epub 2018 Mar 7. Vaccine. 2018. PMID: 29525283 Free PMC article.
Development of standard clinical endpoints for use in dengue interventional trials.
Tomashek KM, Wills B, See Lum LC, Thomas L, Durbin A, Leo YS, de Bosch N, Rojas E, Hendrickx K, Erpicum M, Agulto L, Jaenisch T, Tissera H, Suntarattiwong P, Collers BA, Wallace D, Schmidt AC, Precioso A, Narvaez F, Thomas SJ, Edelman R, Siqueira JB, Cassetti MC, Dempsey W, Gubler DJ. Tomashek KM, et al. Among authors: thomas l, thomas sj. PLoS Negl Trop Dis. 2018 Oct 4;12(10):e0006497. doi: 10.1371/journal.pntd.0006497. eCollection 2018 Oct. PLoS Negl Trop Dis. 2018. PMID: 30286085 Free PMC article.
Dengue illness index-A tool to characterize the subjective dengue illness experience.
Thomas SJ, Agulto L, Hendrickx K, Erpicum M, Tomashek KM, Cassetti MC, Laughlin C, Precioso A, Schmidt AC, Narvaez F, Siqueira JB, Tissera H, Edelman R. Thomas SJ, et al. PLoS Negl Trop Dis. 2018 Oct 4;12(10):e0006593. doi: 10.1371/journal.pntd.0006593. eCollection 2018 Oct. PLoS Negl Trop Dis. 2018. PMID: 30286086 Free PMC article.
549 results